Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 6
Submit an article Journal homepage
322
Views
10
CrossRef citations to date
0
Altmetric
Review

Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism

Mario Cozzolino University of Milan, S. Paolo Hospital, Renal Division, Via A di Rudinì, 8 – 20142, Milan, Italy +39 02 8184 4381; +39 02 8912 9989; [email protected]
, MD PhD &
Diego Brancaccio University of Milan, S. Paolo Hospital, Renal Division, Via A di Rudinì, 8 – 20142, Milan, Italy +39 02 8184 4381; +39 02 8912 9989; [email protected]
, MD
Pages 947-954 | Published online: 01 Apr 2008

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mario Cozzolino & Markus Ketteler. (2019) Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD). Expert Opinion on Pharmacotherapy 20:17, pages 2081-2093.
Read now

Articles from other publishers (9)

Mario Cozzolino, Paola Minghetti & Pierluigi Navarra. (2021) Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D. Journal of Nephrology 35:3, pages 863-873.
Crossref
Fabiana Rodrigues Hernandes, Patrícia Goldenstein & Melani Ribeiro Custódio. (2021) Treatment of Hyperparathyroidism (SHPT). Brazilian Journal of Nephrology 43:4 suppl 1, pages 645-649.
Crossref
Amin Ussif, Hege Pihlstrøm, Andreas Pasch, Hallvard Holdaas, Anders Hartmann, Knut Smerud & Anders Åsberg. (2018) Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score. BMC Nephrology 19:1.
Crossref
Hege Kampen Pihlstrøm, Franscesca Gatti, Clara Hammarström, Ivar Anders Eide, Monika Kasprzycka, Junbai Wang, Guttorm Haraldsen, My Hanna Sofia Svensson, Karsten Midtvedt, Geir Mjøen, Dag Olav Dahle, Anders Hartmann & Hallvard Holdaas. (2017) Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study. Transplant International 30:8, pages 827-840.
Crossref
A Azak, B Huddam, N Haberal, G Koçak, L Ortabozkoyun, M Şenes, MF Akdoğan, N Denizli & M Duranay. (2013) Effect of novel vitamin D receptor activator paricalcitol on renal ischaemia/reperfusion injury in rats. The Annals of The Royal College of Surgeons of England 95:7, pages 489-494.
Crossref
Fouad Al-Baaj, Punit Yadav & Adriece Al-Rifai. (2011) PARICALCITOL IN SECONDARY HYPERPARATHYROIDISM AND THE SURVIVAL BENEFIT IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Journal of Renal Care 37:2, pages 75-79.
Crossref
Neal Mittman, Brinda Desiraju, Kevin B. Meyer, Jyoti Chattopadhyay & Morrell M. Avram. (2010) Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study. Kidney International 78, pages S33-S36.
Crossref
Klára Sochorová, Vít Budinský, Daniela Rožková, Zuzana Tobiasová, Sylvie Dusilová-Sulková, Radek Špíšek & Jiřina Bartůňková. (2009) Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clinical Immunology 133:1, pages 69-77.
Crossref
. (2009) Current World Literature. Current Opinion in Pediatrics 21:4, pages 553-560.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.